Engineers Gate Manager’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,960
Closed -$244K 2352
2024
Q4
$244K Buy
22,960
+11,327
+97% +$137K ﹤0.01% 1809
2024
Q3
$170K Buy
+11,633
New +$165K ﹤0.01% 1834
2024
Q2
Sell
-10,536
Closed -$260K 2074
2024
Q1
$260K Buy
+10,536
New +$214K 0.01% 1534

Other funds holding IMNM

Engineers Gate Manager's IMNM Position: Q1 2025 in Review

Engineers Gate Manager sold out of Immunome (IMNM) in Q1 2025, closing a stake of 22,960 shares — an estimated $244K sold.

Engineers Gate Manager first reported a position in IMNM in Q1 2024 and held it in 3 quarters. The position peaked at $260K in Q1 2024. 142 funds tracked by Wall St. Rank hold IMNM as of Q1 2025.

  • Engineers Gate Manager reported no remaining Immunome position as of Q1 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 22,960 Immunome shares in Q1 2025, an estimated $244K.
  • Engineers Gate Manager first reported a position in Immunome in Q1 2024 and held it in 3 quarters.
  • Engineers Gate Manager's Immunome position peaked at $260K in Q1 2024.
  • 142 funds tracked by Wall St. Rank held Immunome as of Q1 2025.

Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.